Elemental iron

Phase 2Small molecule

UUniversity of Texas Southwestern Medical Center

Elemental iron is one of 71 small molecule programs targeting Iron deficiency anemia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron Deficiency AnemiaActive, not recruiting

AnemiaActive, not recruiting

Iron Deficiency AnemiaPhase 2

Active, not recruiting

AnemiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

272 competitors in Anemia

#DrugCompanyPhaseTrials

Rituxan

Roche

Phase 3

2 2

Ultomiris

AstraZeneca

Phase 3

1 3

Feosol

AAuerbach Hematology Oncology Associates P C

Phase 3

9 4

Soliris

AstraZeneca

Phase 3

1 5

Cytoxan

BBaxter Healthcare Corporation

Phase 3

6 6

Vafseo

AAkebia Therapeutics

Phase 3

4 7

Omontys

Takeda

Phase 3

9 8

Campath

GGenzyme, a Sanofi Company

Phase 3

2 9

Alkeran

AApotex Inc.

Phase 3

1 10

Jesduvroq

GGlaxo Dba Glaxosmithkline

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Recruiting

Anemia

NCT07397572

Clinical

Trials by Indication[1]

Iron deficiency anemia3 trials

Effect of Iron and Vitamin D Supplementation to Iron Status in Iron Deficiency Anemia

Completed·NNadirah Rasyid Ridha·N/A·NCT06148545·57 enrolled

Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia

Completed·UUniversity of Texas Southwestern Medical Center·Phase 4·NCT01904864·80 enrolled

Impact of One Versus Two Amino Acid Chelated Iron Capsules on Prevention of Iron Deficiency Anemia in Non-anemic Women With Twin Gestations

Completed·—·Phase 2·NCT02858505·120 enrolled

Anemia2 trials

Iron Supplementation and Anemia After Sleeve Gastrectomy

Recruiting·—··NCT07397572·66 enrolled

Iron-Deficiency Anemia in Infants in Two Weekly Programs

Completed·SSao Jose do Rio Preto Medical School·N/A·NCT00655408·130 enrolled

Low Birth Weight1 trial

Timing of Iron Supplementation in Very Low Birth Weight Infants

Completed·—·N/A·NCT00683527·46 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Elemental iron. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Elemental iron compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Elemental iron. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Texas Southwestern Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Texas Southwestern Medical Center

Elemental iron

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Iron deficiency anemia3 trials

Anemia2 trials

Low Birth Weight1 trial

References

Drug Info

Quick Facts

Related News